Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-24 Sale | 2024-01-25 06:13 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 3,703,703 | $8.1 | $29,999,994 | 3,755,583 (Direct) | View |
| 2022-03-14 Sale | 2022-03-16 8:10 pm | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 18 | $19 | $342 | 7,459,286 (Direct) | View |
| 2021-12-07 Sale | 2021-12-09 06:04 am | Day One Biopharmaceuticals Inc. | DAWN | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. MILLENNIUM PHARMACEUTICALS INC Takeda Ventures Inc. 10% Owner | 297,273 | $18.49 | $5,496,869 | 6,120,124 (Indirect) | View |
| 2021-12-03 Sale | 2021-12-07 06:01 am | Day One Biopharmaceuticals Inc. | DAWN | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. MILLENNIUM PHARMACEUTICALS INC Takeda Ventures Inc. 10% Owner | 110,209 | $18.1 | $1,994,530 | 6,417,397 (Indirect) | View |
| 2021-11-04 Sale | 2021-11-08 06:04 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 1,000,001 | $20.85 | $20,850,019 | 7,459,304 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-03-18 06:19 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Kim Julie So-Young CEO - Elect | 0 | $0 | 324,729 (Direct) | View |
Ownership | 2026-03-18 06:18 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Furney Natalie Anne Marie Global General Counsel | 0 | $0 | 191,280 (Direct) | View |
Ownership | 2026-03-18 06:17 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Bitetti Teresa Marie President, OBU | 0 | $0 | 193,148 (Direct) | View |
Ownership | 2026-03-18 06:17 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Pignagnoli Agosti Marcello Global Bus. Devel. Officer | 0 | $0 | 144,608 (Direct) | View |
Ownership | 2026-03-18 06:17 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | FUJIMORI YOSHIAKI Director | 0 | $0 | 37,207 (Direct) | View |
Ownership | 2026-03-18 06:16 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Higashi Emiko Director | 0 | $0 | 32,356 (Direct) | View |
Ownership | 2026-03-18 06:16 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Miyabashira Asuka President, Japan Pharma B.U. | 0 | $0 | 5,260 (Direct) | View |
Ownership | 2026-03-18 06:16 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Ricci Gabriele Chief Data & Tech. Officer | 0 | $0 | 124,132 (Direct) | View |
Ownership | 2026-03-18 06:15 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Reed Kimberly A. Director | 0 | $0 | 22,199 (Direct) | View |
Ownership | 2026-03-18 06:15 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Pacheco Rhonda Janice President, U.S. Business Unit | 0 | $0 | 149,252 (Direct) | View |
Ownership | 2026-03-18 06:15 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Orsinger Michel Bruno Director | 0 | $0 | 27,356 (Direct) | View |
Ownership | 2026-03-18 06:13 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Shannon Elaine Mary Global Quality Officer | 0 | $0 | 57,580 (Direct) | View |
Ownership | 2026-03-18 06:13 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | BUTEL JEAN LUC Director | 0 | $0 | 27,356 (Direct) | View |
Ownership | 2026-03-18 06:12 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Tsusaka Miki Director | 0 | $0 | 13,224 (Direct) | View |
Ownership | 2026-03-18 06:12 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Furuta Milano Chief Financial Officer | 0 | $0 | 70,552 (Direct) | View |
Ownership | 2026-03-18 06:11 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Weber Christophe Pierre President and CEO | 0 | $0 | 1,285,362 (Direct) | View |
Ownership | 2026-03-18 06:11 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | MARAGANORE JOHN Director | 0 | $0 | 20,824 (Direct) | View |
Ownership | 2026-03-18 06:11 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Platford Giles Richard President, PDT | 0 | $0 | 225,239 (Direct) | View |
Ownership | 2026-03-18 06:10 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | CLARK IAN T Director | 0 | $0 | 25,276 (Direct) | View |
Ownership | 2026-03-18 06:09 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | GILLIS STEVEN Director | 0 | $0 | 31,437 (Direct) | View |
Ownership | 2026-03-18 06:08 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Plump Andrew Stewart President, R&D | 0 | $0 | 875,409 (Direct) | View |
Ownership | 2026-03-18 06:07 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Duprey Lauren Rusckowski Chief HR Officer | 0 | $0 | 168,513 (Direct) | View |
Ownership | 2026-03-18 06:06 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Iijima Masami Director | 0 | $0 | 19,625 (Direct) | View |
Ownership | 2026-03-18 06:06 am | N/A N/A | TAKEDA PHARMACEUTICAL CO LTD | TAK | Hatsukawa Koji Director | 0 | $0 | 34,976 (Direct) | View |
| 2025-12-08 Conversion | 2025-12-09 9:19 pm | N/A N/A | Ovid Therapeutics Inc. | OVID | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. 10% Owner | 1,251,250 | $0 | 8,781,996 (Indirect) | View |
| 2025-09-17 Equity Swap | 2025-09-19 07:23 am | N/A N/A | HilleVax Inc. | HLVX | TAKEDA PHARMACEUTICAL CO LTD Takeda Vaccines Inc. 10% Owner | 6,724,000 | $1.95 | 0 (Indirect) | View |
| 2023-04-17 Other | 2023-05-26 07:08 am | 2021-10-18 N/A | Calithera Biosciences Inc. | CALA | TAKEDA PHARMACEUTICAL CO LTD Takeda Ventures Inc. Former 10% Owner | 1,000,000 | $0 | 0 (Indirect) | View |
| 2022-11-30 Exercise | 2022-12-01 5:47 pm | 2022-05-03 2031-07-02 | HilleVax Inc. | HLVX | TAKEDA PHARMACEUTICAL CO LTD Takeda Vaccines Inc. 10% Owner | 5,883,500 | $0 | 6,724,000 (Indirect) | View |
| 2022-07-01 Other | 2022-07-06 06:28 am | N/A N/A | Ovid Therapeutics Inc. | OVID | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. 10% Owner | 5,752,500 | $0 | 19,033,246 (Indirect) | View |
| 2022-07-01 Other | 2022-07-06 06:18 am | 2021-10-18 N/A | Calithera Biosciences Inc. | CALA | TAKEDA PHARMACEUTICAL CO LTD Takeda Ventures Inc. 10% Owner | 2,000,000 | $0 | 1,000,000 (Indirect) | View |
Ownership(A) | 2022-05-09 06:10 am | N/A N/A | HilleVax Inc. | HLVX | TAKEDA PHARMACEUTICAL CO LTD Takeda Vaccines Inc. 10% Owner | 0 | $0 | 6,724,000 (Indirect) | View |
Ownership | 2022-04-29 06:02 am | N/A N/A | HilleVax Inc. | HLVX | TAKEDA PHARMACEUTICAL CO LTD Takeda Vaccines Inc. 10% Owner | 0 | $0 | 4,000,000 (Indirect) | View |
Ownership | 2022-04-21 06:03 am | 2021-10-18 N/A | Calithera Biosciences Inc. | CALA | TAKEDA PHARMACEUTICAL CO LTD MILLENNIUM PHARMACEUTICALS INC 10% Owner | 0 | $0 | 1,000,000 (Indirect) | View |
| 2022-03-14 Exercise | 2022-03-16 8:10 pm | 2019-10-29 2029-05-07 | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 7,359,304 | $0 | 7,459,286 (Direct) | View |
| 2021-11-24 Other | 2021-11-29 5:16 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. MILLENNIUM PHARMACEUTICALS INC Takeda Ventures Inc. 10% Owner | 57,224 | $0 | 6,584,830 (Indirect) | View |
| 2021-11-04 Exercise | 2021-11-08 06:04 am | 2019-10-29 2029-05-07 | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 228,696 | $0 | 7,459,304 (Direct) | View |
| 2021-10-26 Conversion | 2021-10-26 8:31 pm | N/A N/A | Xilio Therapeutics Inc. | XLO | TAKEDA PHARMACEUTICAL CO LTD Takeda Ventures Inc. 10% Owner | 2,950,242 | $0 | 1,475,121 (Indirect) | View |